Plus Therapeutics Inc (PSTV)

Feb 27, 2026

138,897,548 Common Stock of Plus Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-FEB-2026. - marketscreener.com

Feb 27, 2026

Feb 27, 2026

Certain Warrants of Plus Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-FEB-2026. - marketscreener.com

Feb 27, 2026

Feb 27, 2026

Certain Restricted Stock Units of Plus Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-FEB-2026. - marketscreener.com

Feb 27, 2026

Feb 27, 2026

Lake Street Sticks to Their Buy Rating for Plus Therapeutics (PSTV) - The Globe and Mail

Feb 27, 2026

Feb 27, 2026

Plus Therapeutics (PSTV) CFO granted RSUs and stock options package - Stock Titan

Feb 27, 2026

Feb 27, 2026

PLUS Therapeutics (PSTV) CEO receives large RSU and stock option grants - Stock Titan

Feb 27, 2026

Feb 26, 2026

PLUS THERAPEUTICS, Inc.Common Stock (NQ: PSTV - The Chronicle-Journal

Feb 26, 2026

Feb 25, 2026

PSTV SEC FilingsPlus Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 25, 2026

Feb 25, 2026

Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ - Bitget

Feb 25, 2026

Feb 25, 2026

Plus Therapeutics, Inc. Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ - marketscreener.com

Feb 25, 2026

Feb 25, 2026

Plus Therapeutics (PSTV) Gains New CPT Code for Innovation in Br - GuruFocus

Feb 25, 2026

Feb 25, 2026

Plus Therapeutics announces new Category III CPT code - marketscreener.com

Feb 25, 2026

Feb 25, 2026

Plus Therapeutics Receives AMA Approval for New CPT Code for REYOBIQ in Treatment of CNS Cancers - Quiver Quantitative

Feb 25, 2026

Feb 25, 2026

New AMA code tracks REYOBIQ therapy in aggressive brain cancers - Stock Titan

Feb 25, 2026

Feb 25, 2026

PSTV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 25, 2026

Feb 20, 2026

Value Recap: Is Plus Therapeutics Inc stock undervalued right nowWeekly Stock Summary & Short-Term Swing Trade Alerts - baoquankhu1.vn

Feb 20, 2026

Feb 19, 2026

Aug EndMonth: Is Plus Therapeutics Inc stock undervalued right nowMarket Weekly Review & Comprehensive Market Scan Reports - baoquankhu1.vn

Feb 19, 2026

Feb 14, 2026

Is Plus Therapeutics Inc. in accumulation or distribution phase2025 Retail Activity & Short-Term Trading Opportunity Alerts - mfd.ru

Feb 14, 2026

Feb 14, 2026

Plus Therapeutics Updates Executive Compensation, Approves 2025 Bonuses - The Globe and Mail

Feb 14, 2026

Feb 14, 2026

Aug Gainers: Can Plus Therapeutics Inc stock double in the next yearJuly 2025 Drop Watch & Stock Timing and Entry Methods - baoquankhu1.vn

Feb 14, 2026

Feb 14, 2026

Is Plus Therapeutics Inc. stock showing strong momentumGlobal Markets & Trade Opportunity Analysis - mfd.ru

Feb 14, 2026

Feb 12, 2026

Can Plus Therapeutics Inc. stock double in the next year2025 Retail Activity & Daily Market Momentum Tracking - mfd.ru

Feb 12, 2026

Feb 12, 2026

Aug Decliners: Can Plus Therapeutics Inc stock double in the next yearQuarterly Risk Review & Capital Efficient Trading Techniques - baoquankhu1.vn

Feb 12, 2026

Feb 09, 2026

Aug EndMonth: What is MPWRs valuation compared to sectorStock Surge & Risk Controlled Swing Trade Alerts - baoquankhu1.vn

Feb 09, 2026

Feb 06, 2026

How Analyst Revisions Are Rewriting The Story For Plus Therapeutics (PSTV) - Yahoo Finance

Feb 06, 2026

Feb 06, 2026

Merger Talk: What is the dividend yield of Plus Therapeutics IncPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn

Feb 06, 2026

Feb 06, 2026

Plus Therapeutics (PSTV) Gets a Buy from Lake Street - The Globe and Mail

Feb 06, 2026

Jan 31, 2026

Market Rankings: Is Plus Therapeutics Inc stock undervalued right nowBond Market & Daily Entry Point Alerts - baoquankhu1.vn

Jan 31, 2026

Jan 31, 2026

Exit Recap: What is Atlas Lithium Corporations revenue forecastJuly 2025 Movers & AI Enhanced Execution Alerts - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

Plus Therapeutics shares climb after subsidiary secures nationwide Humana coverage - MSN

Jan 30, 2026

Jan 30, 2026

Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial OfferingSlideshow (NASDAQ:PSTV) 2026-01-30 - Seeking Alpha

Jan 30, 2026

Jan 29, 2026

Is Plus Therapeutics Inc. a top pick in the sectorQuarterly Risk Review & Free Technical Pattern Based Buy Signals - mfd.ru

Jan 29, 2026

Jan 28, 2026

Bond Watch: What is the cash position of LifeMD IncJuly 2025 Momentum & Weekly High Momentum Picks - baoquankhu1.vn

Jan 28, 2026

Jan 26, 2026

Published on: 2026-01-27 09:16:26 - baoquankhu1.vn

Jan 26, 2026

Jan 26, 2026

Institution Moves: Is Plus Therapeutics Inc on track to beat earningsTrade Signal Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn

Jan 26, 2026

Jan 26, 2026

Price Action: Is Euroholdings Ltd. stock showing strong momentumJuly 2025 Recap & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Jan 26, 2026

Jan 23, 2026

H.C. Wainwright lowers Plus Therapeutics stock price target on equity offering - Investing.com India

Jan 23, 2026

Jan 23, 2026

Maxim Group Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Cuts Target Price to $1.5 - 富途牛牛

Jan 23, 2026

Jan 23, 2026

Plus Therapeutics secures $5.7M to support leptomeningeal metastases program - MSN

Jan 23, 2026

Jan 23, 2026

H.C. Wainwright Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Cuts Target Price to $1 - 富途牛牛

Jan 23, 2026

Jan 23, 2026

Plus Therapeutics (PSTV) Sees Price Target Cut by HC Wainwright | PSTV Stock News - GuruFocus

Jan 23, 2026

Jan 22, 2026

Plus Therapeutics outlines 2026 goals for cancer treatments and diagnostics By Investing.com - Investing.com South Africa

Jan 22, 2026

Jan 22, 2026

Aug Mood: Is ABCL forming higher highs and higher lowsJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - baoquankhu1.vn

Jan 22, 2026

Jan 22, 2026

Market Review: What dividend growth rate does Plus Therapeutics Inc offerWeekly Gains Summary & Precise Swing Trade Entry Alerts - baoquankhu1.vn

Jan 22, 2026

Jan 22, 2026

Plus Therapeutics, Inc. Provides Business Update on REYOBIQ Clinical Program and U.S. CNSide Commercialization - marketscreener.com

Jan 22, 2026

Jan 22, 2026

PSTV: $15M raise funds clinical and commercial growth; CNSIDE targets break-even by 2027 - TradingView — Track All Markets

Jan 22, 2026

Jan 22, 2026

Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET - Sahm

Jan 22, 2026

Jan 22, 2026

Plus Therapeutics Sets 2026 Milestones For REYOBIQ Clinical Program And CNSide Commercial Rollout - Nasdaq

Jan 22, 2026

Jan 22, 2026

Plus Therapeutics outlines 2026 goals for cancer treatments and diagnostics - Investing.com

Jan 22, 2026

Jan 22, 2026

PSTV Analyst Rating Update: Price Target Lowered to $4.00 | PSTV Stock News - GuruFocus

Jan 22, 2026

Jan 22, 2026

Plus Therapeutics Sharpens Focus on CNS Cancer Strategy - TipRanks

Jan 22, 2026

Jan 22, 2026

PSTV: 2026 focus: CNSide scale-up, REYOBIQ pivotal trial prep, and expanded payor coverage - TradingView

Jan 22, 2026

Jan 22, 2026

Plus Therapeutics Provides Business Update on REYOBIQ™ Clinical Program and U.S. CNSide® Commercialization - manilatimes.net

Jan 22, 2026

Jan 22, 2026

Plus Therapeutics, Inc. Updates Corporate Presentation on Cancer Radiotherapeutics - TradingView

Jan 22, 2026

Jan 22, 2026

Plus Therapeutics To Provide Business Update Today As Radiotherapeutic Pipeline Advances - Nasdaq

Jan 22, 2026

Jan 21, 2026

Plus Therapeutics To Provide Business Update On Thursday - TradingView

Jan 21, 2026

Jan 21, 2026

Plus Therapeutics, Inc. to Host Business Update and Conference Call on January 22, 2026 | PSTV Stock News - Quiver Quantitative

Jan 21, 2026

Jan 21, 2026

Plus Therapeutics to Provide Business Update and Host - GlobeNewswire

Jan 21, 2026